Late-Stage Private Markets

Where Smart
Investors Meet
Opportunity

We identify and invest in late-stage private companies with strong fundamentals, a clear path to profitability, and a defined exit strategy.

36–48mo
Target Exit Window
85%
Late-Stage Private Equity
15%
Early-Stage / Pre-IPO
Scroll
Technology
Fintech
Healthcare
Consumer Innovation
Private Equity
M&A Advisory
IPO Readiness
Capital Markets
Technology
Fintech
Healthcare
Consumer Innovation
Private Equity
M&A Advisory
IPO Readiness
Capital Markets

Partners
in Growth

At BlueRock Capital, we concentrate on identifying and investing in later-stage private companies with strong fundamentals, a clear path to profitability, and a defined exit strategy.

Our primary focus is on companies positioned for acquisition or IPO within 36–48 months, maximizing returns while mitigating risk. We bring decades of experience in finance, private equity, and capital markets.

"We don't just invest — we build paths to exceptional exits."

— BlueRock Capital

36
Month Avg. Exit

Disciplined.
Data-Driven.

We assess every opportunity through a rigorous framework built on market dynamics, revenue trajectory, leadership quality, and exit viability — ensuring every investment is positioned for success.

01
Market Readiness

We evaluate whether a company is operating in a market that is active, accessible, and capable of supporting sustained growth. This includes market size, timing, customer adoption, and real demand versus speculative interest. We focus on markets where capital, customers, and strategic buyers are engaged, with the ability to support a clear and achievable exit.

02
Revenue Trajectory

We focus on the quality and durability of revenue growth. This includes consistency of growth, visibility into future revenue, unit economics, and the ability to scale without disproportionate increases in cost. Preference is given to businesses with repeatable revenue models and clear pathways to improving margins over time.

03
Leadership Strength

We assess the experience, execution capability, and alignment of the leadership team. This includes their ability to scale the business, allocate capital effectively, and navigate both growth and adversity. We prioritize teams with demonstrated discipline, clear decision-making, and a track record of building value.

04
Exit Viability

We evaluate the likelihood of a defined and achievable liquidity event. This includes potential acquirers, market appetite, comparable transactions, and the company's positioning within its sector. Each investment is assessed with a clear view of how and when capital can be returned.

Focused
Where It Matters

Our portfolio is deliberately concentrated in late-stage opportunities, while maintaining strategic exposure to high-potential early-stage ventures.

Late-Stage85%
Early-Stage15%

High-Growth
Industries

Technology
Fintech
Healthcare
Consumer
SaaS
Marketplace

Leadership
Built on
Conviction

Three Managing Partners. Decades of experience spanning Naval Special Warfare, Olympic athletics, private equity, and global capital markets. We don't just invest — we've built, scaled, and exited.

Tim Roach
Tim Roach
Managing Partner

Tim Roach is a seasoned entrepreneur and investor with more than three decades of experience across financial markets, private investing, and operating businesses — spanning the Chicago Board of Trade, CBOE, and CME, where he traded complex index and derivatives strategies.

He founded OakStreet Trading, a commodities firm with 15 consecutive years of profitability, and co-founded Lendr, a fintech lender for small and medium-sized businesses, where he served as CEO. Before his financial career, Tim served with Naval Special Warfare.

Over his career, Tim has helped raise more than $100 million. He is known for his disciplined approach to risk, capital structure, and identifying the clearest path to exit — bringing a differentiated edge to BlueRock's investment process.

NSW $100M+ Raised Commodities Fintech
Dermot Bolger
Dermot Bolger
Managing Partner

Co-founder and former Managing Partner at ID Fund Advisors (2018–2025), where he managed over $250 million across three funds and 25+ portfolio companies in both the U.S. and Europe.

Dermot combined rigorous due diligence with active portfolio management and client relationships, driving strong fund performance. He brings deep expertise in SaaS, healthcare, and AI/chip sectors, with hands-on experience overseeing operations, legal, tax, compliance, and portfolio company negotiations.

$250M AUM SaaS Healthcare AI / Chips
Tucker Perkins
Tucker Perkins
Managing Partner

A rare combination of elite athlete and accomplished operator. Tucker was the first freeskier signed to Nike at 14, one of the first athletes signed to GoPro, and a US National Champion in 2010 — reaching a #2 world ranking in 2011.

After retiring from competition, Tucker moved into defense manufacturing with Wilcox Industries, leading programs in Qatar and the Middle East. He joined a late-stage private fund in 2022 and raised over $70M in his first 18 months.

US National Champion Defense $70M+ Raised Late-Stage

Explore
Opportunities

Reach out to schedule a meeting with our team and explore exclusive investment opportunities tailored to your goals.

Investor Portal
invest.bluerockcapital.co